High performance liquid chromatographic determination of some guaiphenesin-containing cough-cold preparations  by Korany, Mohamed A. et al.
Journal of Advanced Research (2011) 2, 121–130Cairo University
Journal of Advanced ResearchORIGINAL ARTICLEHigh performance liquid chromatographic determination
of some guaiphenesin-containing cough-cold preparationsMohamed A. Korany *, Ossama T. Fahmy, Hoda Mahgoub, Hadir M. MaherDepartment of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, University of Alexandria, Alexandria 21521, EgyptReceived 8 May 2010; revised 11 August 2010; accepted 13 August 2010
Available online 25 October 2010*
E-
20
El
Pe
doKEYWORDS
Salbutamol sulfate;
Guaiphenesin;
Ascorbic acid;
Paracetamol;
Ambroxol hydrochloride;
HPLCCorresponding author. Tel.:
mail address: makorany@ya
90-1232 ª 2010 Cairo Un
sevier B.V. All rights reserve
er review under responsibilit
i:10.1016/j.jare.2010.09.005
Production and h+20 3 4
hoo.com
iversity.
d.
y of Cair
osting by EAbstract This paper presents different HPLC methods for the simultaneous determination of some
guaiphenesin-containing cough-cold preparations. Three pharmaceutically available combinations
were analyzed: salbutamol sulfate (SAL) and guaiphenesin (GUA), combination I; ascorbic acid
(ASC), paracetamol (PAR) and guaiphenesin (GUA), combination II; and theophylline anhydrous
(THE), guaiphenesin (GUA) and ambroxol hydrochloride (AMB), combination III. A
250 · 4.6 mm C-18 column was used for all combinations. The mobile phase for the three combina-
tions consisted of a mixture of methanol and 0.01 M aqueous phosphate buffer solution. The pH of
the mobile phase was adjusted to 3.2, 6.2 and 3.8 for combinations I, II and III, respectively. The pro-
posedHPLCmethodswere successfully applied to the determination of the investigated drugs, both in
syntheticmixtures and in pharmaceutical preparations, without anymatrix interference andwith high
precision and accuracy. Different aspects of analytical validation are presented in the text.
ª 2010 Cairo University. Production and hosting by Elsevier B.V. All rights reserved.Introduction
Due to the vast number of papers dealing with the analysis of
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lsevierdetermination of SAL in pharmaceuticals by liquid chroma-
tography–mass spectrometry (LC–MS) [1], capillary electro-
phoresis (CE) [2], cyclic voltammetry [3] present there.
Different methods including high-performance liquid chroma-
tography (HPLC) [4] and capillary electrochromatography
(CEC) [5] have been applied for the enantiomeric separation
of SAL. SAL has been determined in biological media using
LC–MS [6], CE [2] and HPLC [7].
Several methods have been reported for the determination
of GUA in pharmaceutical mixtures. These include the analy-
sis of anti-cough preparations by spectrophotometry [8,9],
micellar electrokinetic chromatography (MEKC) [10] and
HPLC [8,9]. Enantioseparation of GUA has been reported
using simulated moving bed chromatography [11]. For the as-
say of GUA in plasma, liquid chromatography (LC) [12] meth-
ods have been applied.
Literally, thousands of papers have been published for the
determination of ASC. Multivitamin preparations containing
Table 2 Chromatographic characteristics of drug combina-
tions I, salbutamol sulfate (SAL) and guaiphenesin (GUA), II,
ascorbic acid (ASC), paracetamol (PAR) and guaiphenesin
(GUA) and III, theophylline (THE), guaiphenesin (GUA) and
ambroxol hydrochloride (AMB) by the proposed HPLC
methods.
tR
a Nb K0c ad Rs
e Tf
f
Combination I
SAL 2.86 1394 0.68 1.01
2.77 7.33
GUA 4.90 4444 1.88 1.07
Combination II
ASC 2.00 1708 0.18 1.02
4.67 4.00
PAR 3.10 1672 0.82 1.07
1.93 4.89
GUA 4.40 3654 1.59 1.08
Combination III
THE 3.00 2304 0.76 1.08
1.58 3.20
GUA 3.76 4702 1.21 1.12
2.24 8.89
AMB 6.30 5289 2.70 1.18
a Retention time, in min.
b Number of theoretical plates.
c Capacity factor.
d Selectivity, between each two successive peaks.
e Resolution, between each two successive peaks.
f Tailing factor.
122 M.A. Korany et al.ASC have been assayed for its vitamin contents by LC [13] and
MEKC [14]. HPLC [15] has been applied for the determination
of anti-cold pharmaceutical mixtures containing ASC. For the
determination of ASC in fruit juices, various methods includ-
ing HPLC [16] have been found beneﬁcial.
PAR has been determined using many reported methods.
Pharmaceutical combinations containing PAR have been ana-
lyzed by spectrophotometry [17], LC [18] and MEKC [19]. In
biological ﬂuids, PAR has been determined using HPLC [20].
Several methods have been reported for the determination
of THE. In pharmaceutical preparations, THE has been deter-
mined by HPLC [21]. Mixtures containing THE could be as-
sayed using different analytical methods that include infra-
red spectroscopy [22], HPLC [23] and CEC [24]. THE has been
determined in biological ﬂuids by HPLC [25]. HPLC [26] and
LC–MS [27] have been applied for the determination of THE
and its metabolites in serum. Tea samples have been analyzed
for THE content by HPLC [28]. Separation of the drug enan-
tiomers has been accomplished using HPLC [29].
Different methods have been reported for the determina-
tion of AMB either in biological ﬂuids or in pharmaceutical
preparations. Simultaneous determination of AMB with other
drugs in pharmaceutical mixtures has been applied using
HPLC [30,31]. AMB has been determined in biological ﬂuids
by HPLC [32].
GUA may be given with SAL, combination I, as an expec-
torant and cough-sedative or with ASC and PAR, combina-
tion II, as analgesic, antipyretic and expectorant useful in
inﬂuenza and common cold. Also GUA can be given in com-
bination with THE and AMB, combination III, as mucolytic,
expectorant and bronchodilator.
Review of the literature reveals that the resolution of mul-
ticomponent mixtures containing SAL and GUA along with
methyl paraben and propyl paraben preservatives has been
accomplished in their syrup by using numerical spectrophoto-
metric methods such as partial least squares (PLS-1) and prin-
cipal component regression (PCR) [8]. In addition an HPLC
method was also developed for the same purpose [8]. Simulta-
neous assay of SAL and GUA in pharmaceutical preparations
by microbore column liquid chromatography has also been re-
ported [33].
Also the simultaneous determination of GUA, THE to-
gether with diphenhydramine hydrochloride, methylparaben,
propylparaben and sodium benzoate in pharmaceutical syrup
has been developed [9]. This was performed using two chemo-
metric methods; partial least squares (PLS-1) and principal
component regression (PCR), and an HPLC method. Both
HPLC methods [8,9] were developed using a RP C18 column
with mobile phase consisting of acetonitrile–phosphate buffer
with UV detection. The methods were validated in terms of
accuracy, speciﬁcity, precision and linearity in the range ofTable 1 Chromatographic conditions used for combinations I, II a
Combination Flow rate
(ml/min)
Mobile phase composition
MeOH
% (v/v)
Aqueous phase%* (v/v) pH of the
I 1.5 40 60 3.2
II 1 50 50 6.2
III 1 60 40 3.8
* 0.01 M sodium dihydrogenphosphate solution.20–60 lg/ml for GUA and 1–3 lg/ml for SAL [8] or 5.0–
33.0 lg/ml for THE and 3–21 lg/ml for GUA [9].
In addition, an HPLC method has been developed for the
simultaneous estimation of GUA, AMB along with terbutaline
sulfate in their formulations [30]. The separations were
achieved on a RP C18 column using a mobile phase consisting
of a mixture of water and acetonitrile containing sodium hex-
ane sulphonate (pH 3.0).
To our knowledge, no analytical method has been reported
for the simultaneous determination of the studied combina-
tions (II–III) in their multicomponent pharmaceutical mix-
tures. Only one HPLC method [9] was reported for the
determination of combination I in syrup.
This work describes three rapid, speciﬁc, reliable and sensi-
tive analytical methods based on reversed-phase high perfor-
mance liquid chromatography with UV detection for the
quantitative determination of drugs in the three combinations
whether in synthetic mixtures or in their pharmaceutical prep-
arations. The applied methods depend on the use of methanolnd III.
Run time (min) Detection wavelength (nm)
system
10 275
5 225
10 225 nm for the ﬁrst 4.5 min then 248 nm
HPLC analysis of some cough-cold preparations 123as the organic modiﬁer unlike the previous methods which
use acetonitrile in the mobile phase [8,9]. So they can be
successfully applied when only methanol is available. Moreover,
the proposed HPLC methods are more sensitive compared
with previously published methods [8,9] except for SAL in
reference [8].
Experimental
Instrumentation
The chromatographic system consisted of S 1121 solvent deliv-
ery system (Sykam GmbH, Germany), S 3210 variable-wave-
length UV–VIS detector (Sykam GmbH, Germany) and S
5111 Rheodyne injector valve bracket ﬁtted with a 20 ll sam-
ple loop. HPLC separations were performed on a stainless-
steel ThermoHypersil C-18 analytical column (250 · 4.6 mm)
packed with 5 lm diameter particles. Data were processed
using EZChrom Chromatography Data System, version 6.8
(Scientiﬁc Software, Inc., CA, USA) on an IBM-compatible
PC connected to a printer.
Materials and reagents
Standards of SAL, GUA, ASC, PAR, THE and AMB were
kindly supplied by Pharco Pharmaceuticals Co. (Alex, Egypt).
For combination I, Bronchovent syrup was obtained from
Pharco Pharmaceuticals Co. (Alex, Egypt), labeled to contain
2 mg SAL and 50 mg GUA per 5 ml. For combination II,
G.C.MOL effervescent sachets were obtained from Pharco
Pharmaceuticals Co. (Alex, Egypt) and each sachet is labeled
to contain 250 mg ASC, 325 mg PAR and 100 mg GUA. For
combination III, Farcosolvin syrup was obtained from
Pharco Pharmaceuticals Co. (Alex, Egypt), labeled to containTable 3 Regression and statistical parameters for the determina
guaiphenesin (GUA), II, ascorbic acid (ASC), paracetamol (PAR) and
(GUA) and ambroxol hydrochloride (AMB) by the proposed HPLC
Linearity range (lg/ml) Regression data
aa bb rc
Combination I
SAL 8–600 43,214 169,666 0.9995 1
GUA 10–500 51,505 292,280 0.9994 1
Combination II
ASC 4–100 31,263 499,467 0.9992 3
PAR 1–60 72,934 15,50,820 0.9995 9
GUA 2–75 1016 15,06,982 0.9992 3
Combination III
THE 0.5–40 2023 334,825 0.9998 6
GUA 1.5–45 12,329 240,105 0.9998 5
AMB 1–80 6862 110,185 0.9997 2
a Intercept.
b Slope.
c Correlation coefﬁcient.
d Standard deviation of residuals.
e Standard deviation of intercept.
f Standard deviation of slope.
g Limit of detection.
h Limit of quantitation.50 mg THE, 30 mg GUA and 15 mg AMB per 5 ml of the
syrup. All reagents were of analytical grade, namely: methanol
(Panreac Co., E.U.), sodium dihydrogenphosphate, ortho-
phosphoric acid and sodium hydroxide (BDH, Poole, England).
The water for HPLC was double glass distilled.
Chromatographic conditions
In the three combinations, the mobile phase consisted of
methanol and an aqueous phase, which was 0.01 M sodium
dihydrogenphosphate aqueous solution. The pH of the mobile
phase was adjusted to the required value by dropwise addition
of either 0.1 M H3PO4 or 0.1 M NaOH solutions. The used
chromatographic conditions are summarized in Table 1. The
corresponding chromatographic characteristics are mentioned
in Table 2.
The mobile phase was degassed and ﬁltered by passing
through a 0.45 lm pore size membrane ﬁlter (Millipore,
Milford, MA, USA) prior to use. All determinations were
performed at ambient temperature.
Standard solutions and calibration graphs
For combination I, stock solutions were prepared by dissolv-
ing SAL and GUA in methanol to obtain concentrations of
100 and 200 mg%, respectively. For combination II, stock
solutions were prepared by dissolving ASC, PAR and GUA
in methanol to obtain concentrations of 20, 20, and 20 mg%,
respectively. For combination III, stock solutions were pre-
pared by dissolving THE, GUA and AMB in methanol to ob-
tain concentrations of 10, 10, and 20 mg%, respectively. These
stock solutions were further diluted with the mobile phase
(Table 1) to obtain working standard solutions of suitable
concentrations (corresponding to the linearity range stated intion of drug combinations I, salbutamol sulfate (SAL) and
guaiphenesin (GUA) and III, theophylline (THE), guaiphenesin
methods.
Sy/x
d Sa
e Sb
f LODg (lg/ml) LOQh (lg/ml)
32,456 87,731 2606 5.00 8.00
39,546 88,610 5792 5.00 9.00
1,033 321,452 11,668 2.00 4.00
2,807 97,606 27,249 0.20 0.90
7,006 38,954 35,334 0.50 2.00
628 5579 2751 0.30 0.40
605 4718 2326 0.40 1.20
465 2073 1407 0.40 0.60
Table 4 Evaluation of the precision and accuracy for the determination of drug combinations I, salbutamol sulfate (SAL) and
guaiphenesin (GUA), II, ascorbic acid (ASC), paracetamol (PAR) and guaiphenesin (GUA) and III, theophylline (THE), guaiphenesin
(GUA) and ambroxol hydrochloride (AMB) in laboratory-made mixtures by the proposed HPLC methods.
Nominal value in lab-made
mixture (lg/ml)
Recovery (%) ± SDa RSDb (%)
SAL GUA SAL GUA SAL GUA
Combination I
400 20 99.6 ± 0.54 99.9 ± 0.54 0.54 0.54
300 100 100.2 ± 1.12 101.5 ± 1.12 1.12 1.12
20 500 100.8 ± 1.00 100.1 ± 1.00 1.00 1.00
10 400 99.3 ± 0.36 99.2 ± 0.56 0.36 0.56
8 500 99.6 ± 0.15 100.9 ± 0.25 0.15 0.25
ASC PAR GUA ASC PAR GUA ASC PAR GUA
Combination II
10 30 15 99.6 ± 0.21 99.6 ± 0.32 99.6 ± 0.46 0.21 0.32 0.46
15 60 60 99.9 ± 0.53 99.3 ± 0.53 99.6 ± 0.40 0.53 0.53 0.40
40 52 16 99.7 ± 1.00 99.9 ± 0.38 99.1 ± 0.45 1.00 0.38 0.45
5 40 10 100.1 ± 0.30 99.7 ± 0.55 99.1 ± 0.31 0.30 0.55 0.31
40 5 70 99.5 ± 0.12 100.2 ± 0.35 99.9 ± 0.25 0.12 0.35 0.25
THE GUA AMB THE GUA AMB THE GUA AMB
Combination III
40 24 12 100.8 ± 0.84 100.1 ± 0.05 100.1 ± 0.73 0.84 0.05 0.73
35 25 24 100.9 ± 1.02 100.2 ± 1.00 100.1 ± 0.12 1.02 1.00 0.12
20 35 50 101.1 ± 1.10 100.1 ± 0.12 100.0 ± 0.32 1.10 0.12 0.32
10 10 60 98.8 ± 0.56 99.0 ± 0.10 99.9 ± 0.53 0.56 0.10 0.53
5 5 80 99.9 ± 0.75 100.2 ± 0.25 100.2 ± 0.14 0.75 0.25 0.14
a Mean ± standard deviation of three determinations.
b Percentage relative standard deviation.
124 M.A. Korany et al.Table 3). Triplicate 20-ll injections were made for each con-
centration and were chromatographed under the conditions
mentioned in Table 1. The area of each peak was plotted
against the corresponding concentration to obtain the calibra-
tion graph for each compound.
Assay of laboratory-made mixtures
Accurate volumes of each of SAL and GUA (combination I),
ASC, PAR and GUA (combination II) or of THE, GUA and
AMB (combination III) stock solutions were transferred intoTable 5 Determination of drug combinations I, salbutamol sulf
paracetamol (PAR) and guaiphenesin (GUA) and III, theophylline (T
in pharmaceutical preparations by the proposed HPLC methods.
Nominal value (lg/ml) % Found ± S
SAL GUA SAL
Combination I
20 500 99.4 ± 0.33
ASC PAR GUA ASC PAR
Combination II
40 52 16 100.1 ± 0.36 99.9 ±
THE GUA AMB THE GUA
Combination III
40 24 12 99.0 ± 0.26 99.8 ±
a Mean ± standard deviation of ﬁve determinations.
b Percentage relative standard deviation.10-ml volumetric ﬂasks and diluted to volume with the mobile
phase (Table 1) such that the ratios between drugs are as men-
tioned in Table 4. Triplicate 20-ll injections were made for
each mixture solution and were chromatographed under the
conditions described above in Table 1.
Analysis of pharmaceutical formulations
For combination I, 0.5 ml of the syrup was accurately trans-
ferred into a 10-ml volumetric ﬂask and completed to volume
with the mobile phase (Table 1). For combination (II), theate (SAL) and guaiphenesin (GUA), II, ascorbic acid (ASC),
HE), guaiphenesin (GUA) and ambroxol hydrochloride (AMB)
Da RSDb (%)
GUA SAL GUA
100.6 ± 0.52 0.33 0.52
GUA ASC PAR GUA
0.34 99.2 ± 0.61 0.36 0.34 0.61
AMB THE GUA AMB
0.72 99.9 ± 0.47 0.26 0.72 0.47
HPLC analysis of some cough-cold preparations 125content of one sachet was accurately transferred into a beaker
containing 100 ml of water and left for 5 min till no effervescence
was observed then the clear solution was quantitatively trans-
ferred into 250-ml volumetric ﬂask and completed to volume
with water. 0.4 ml of this stock solution was further diluted
to 10 ml in 10 ml volumetric ﬂask using the corresponding mo-
bile phase (Table 1). For combination III, 0.1 ml of the syrup
was diluted with the mobile phase (Table 1) to a 25 ml volu-
metric ﬂask. The prepared solutions of the three combinations
were then chromatographed exactly as under the assay of mix-
tures containing combinations I, II and III as presented in
Table 5.Fig. 1 A typical chromatogram of a 20 ll injection of a standard mix
using the optimized mobile phase.
Fig. 2 A typical chromatogram of a 20 ll injection of a standard mi
combination II, using the optimized mobile phase.Results and discussion
For combination I, an HPLC method was developed for the
simultaneous determination of SAL (0.4 mg/ml) and GUA
(10 mg/ml) in their syrup. The wavelength of 275 nm which
corresponds to kmax of SAL had to be used in the simultaneous
analysis, as the quantity of the drug, GUA was several times
higher than SAL. The selected method allowed the simulta-
neous determination of SAL and GUA peaks at retention
times of 2.86 and 4.90 min, respectively (Fig. 1).
The wavelength of 225 nm was selected for the simulta-
neous determination of combination II components (250 mgture of 300 lg/ml SAL (1) and 100 lg/ml GUA (2), combination I,
xture of 5 lg/ml ASC (1), 15 lg/ml PAR (2) and 7.5 lg/ml GUA,
Fig. 3 A typical chromatogram of a 20 ll injection of a standard mixture of 35 lg/ml THE (1), 25 lg/ml GUA (2) and 24 lg/ml AMB,
combination III, using the optimized mobile phase.
(b)(a)
(c)
0
5
10
15
20
25
30
15 25 35 45
Methanol (%) Methanol (%)
Methanol (%)
R
et
en
tio
n 
tim
e 
(m
in
)
SAL
GUA
0
5
10
15
20
25
30
35
10 30 50 70
R
et
en
tio
n 
tim
e 
(m
in
)
ASC
PAR
GUA
0
2
4
6
8
10
12
14
16
18
35 45 55 65 75
R
et
en
tio
n 
tim
e 
(m
in
)
THE
GUA
AMB
Fig. 4 Variation of the retention times of combinations: I (a), II (b) and III (c) components as a function of the percentage of methanol
in the mobile phase.
126 M.A. Korany et al.
HPLC analysis of some cough-cold preparations 127ASC, 325 mg PAR and 100 mg GUA per sachet) in the effer-
vescent sachets with high sensitivity. Fig. 2 shows the typicalFig. 5 Variation of the retention times of combinations: I (a), II (b) a
Fig. 6 A chromatogram of the prepared syrup solution of 20 lg/m
paraben.chromatogram of a laboratory-made mixture of the three
compounds. The method permitted adequate resolution ofnd III (c) components as a function of the pH of the mobile phase.
l SAL (1), and 500 lg/ml GUA (2), combination I, (a) methyl
128 M.A. Korany et al.the mixture components within reasonable run-time, ASC
being eluted at 2.0 min, PAR at 3.1 and GUA at 4.4 min.
The simultaneous determination of combination III compo-
nents (THE (10 mg/ml), GUA (6 mg/ml) and AMB (3 mg/ml))
in their syrup required the application of the following
wavelength programming, 0–4.5 min at 225 nm then 4.5–
10 min at 248 nm which corresponds to kmax of AMB since
no intermediate wavelength could be used to analyze the three
components in the required proportions simultaneously. The
method allowed the determination of the mixture components
within a reasonable run-time. THE was eluted at 3.0 min,
GUA at 3.76 and AMB at 6.3 min (Fig. 3).
The chromatographic characteristics of the three combina-
tions are summarized in Table 2 which indicates that the pro-
posed HPLC methods permitted adequate resolution of the
mixtures’ components (good resolution and selectivity values)
within reasonable run-time (suitable capacity factors). In addi-
tion, high column efﬁciency was indicated from the large num-
ber of theoretical plates. The degree of peak asymmetry was
also evaluated using the tailing factor which did not exceed
the critical value (1.2) indicating acceptable degree of peak
asymmetry.
Optimization of chromatographic conditions
To optimize the HPLC assay conditions, for the three combi-
nations, the effects of methanol percentage as well as the pH of
the mobile phase were studied.
Effect of methanol percentage in the mobile phase
The mobile phases used were 0.01 M sodium dihydrogen-
phosphate mixed with various proportions of methanol and
adjusted to pH values of 3.2, 6.2 or 3.8 for combinations I, II
and III, respectively. Mixtures of standards of the three
combinations were thus injected and run with mobile phases
of different composition. Fig. 4a–c show the retention times
obtained for combinations I, II and III, respectively as a func-Fig. 7 A chromatogram of the prepared sachet solution of 40 lg/ml Ation of methanol percentage in the mobile phase. Methanol %
of 40, 50 and 60, for combinations I, II and III, respectively,
provided optimum resolution with the most symmetric and
well-deﬁned peaks. At lower methanol content, separation
did occur but with marked tailing and prolonged retention
times. Increasing methanol content led to loss of resolution
and overlapped peaks in some cases.
Effect of pH
The inﬂuence of the pH of the mobile phase was studied by
using mobile phases consisting of mixtures of methanol and
0.01 M sodium dihydrogenphosphate in a ratio of (40: 60,
v/v), (50: 50, v/v) or (60: 40,v/v) for combinations I, II and III,
respectively at various pH values between 3.2 and 6.8 (adjusted
using 0.1 M ortho-phosphoric acid or sodium hydroxide).
These solutions were used as the mobile phases for standard
mixtures of the three combinations. The pH had only a
marked effect on the retention of SAL in combination I and
ASC in combination II, where increased pH values led to an
increase in the retention of SAL and a decrease in that of
ASC (Fig. 5a and b). A pH values of 3.2 and 6.2, for combina-
tions I and II, respectively, were selected as they provided opti-
mum resolution for both combinations. For combination III,
the pH had nearly no effect on the retention times of THE,
GUA and AMB (Fig. 5c). However, the separation was carried
out at pH 3.8 since the highest symmetry and peak height were
observed at such pH for AMB.
From the optimization of chromatographic conditions
mentioned above, experimental conditions were selected based
on best peak shape, highest symmetry, optimum resolution
along with reasonable run-time for the analysis of the three
combinations as follows; the mobile phase for the three combi-
nations consisted of a mixture of methanol and 0.01 M aque-
ous phosphate buffer solution in a ratio of (40:60), (50:50) or
(60:40) for combinations I, II and III, respectively, all are v/v.
For combination I, the pH of the mobile phase was adjusted
to 3.2 and the separation was carried out at a ﬂow rate ofSC (1), 52 lg/ml PAR (2) and 16 lg/ml GUA (3), combination II.
Fig. 8 A chromatogram of the prepared syrup solution of 40 lg/ml THE (1), 24 lg/ml GUA (2) and 12 lg/ml AMB (3), combination
III, (a) saccharin and (b) methyl paraben.
HPLC analysis of some cough-cold preparations 1291.5 ml/min, with UV detection at 275 nm. For combination II,
the mobile phase was adjusted to pH 6.2 and a ﬂow rate of
1.0 ml/min with UV detection at 225 nm was used. For combi-
nation III, the mobile phase was adjusted to pH 3.8 and a ﬂow
rate of 1 ml/min, with wavelength programming, UV detection
at 225 nm for 4.5 min then at 248 nm for 5.5 min, was applied.
Statistical analysis of results
Concentration ranges and calibration graphs
Under the above described experimental conditions, linear
relationships were observed by plotting drug concentrations
against peak area for each compound, the corresponding concen-
tration ranges for the three combinations are listed in Table 3.
The slopes, intercepts and correlation coefﬁcients obtained by
the linear least squares regression treatment of the results
are also given. The high values of the correlation coefﬁcients
(r values greater than 0.999) with negligible intercepts indicate
the good linearity of the calibration graphs. Standard devia-
tions of residuals (Sy/x), of intercept (Sa), and of slope (Sb)
are presented for each compound. (Sy/x) is a measure of the ex-
tent of deviation of the found (measured) y-values from the
calculated ones. The Sy/x value is also involved in the calcula-
tion of Sa and Sb values [34].
Detection and quantitation limits
Limit of detection (LOD) is deﬁned in the BP as the concentra-
tion which has a signal-to-noise ratio of 3:1. For limit of quan-
titation (LOQ), the ratio considered is 10:1 with an RSD value
less than 10%. LOD and LOQ for each compound were calcu-
lated and are presented in Table 3.
Precision and accuracy
In order to assess the precision, as percentage relative standard
deviation (RSD%), and the accuracy, as percentage relative er-
ror (Er%), of the proposed HPLC method, triplicate determi-
nations were carried out on laboratory-made mixtures of
different proportions, for the three combinations. The datashown in Table 4 indicate good accuracy and precision of
the proposed procedure.
Analysis of pharmaceutical formulations
Assays of sample preparations for combinations I, II and III
were carried out as described under the Experimental section.
Then the prepared solutions were chromatographed under
the conditions described in Table 1. Figs. 6–8 represent the
chromatograms of the prepared pharmaceutical preparations
for combinations I, II and III, respectively. Excipients in the
preparations did not interfere in the analysis. For combination
I, the peak appearing at 7.90 min (a) corresponds to methyl
paraben preservative (Fig. 6) while for combination III, the
peaks appearing at 2.48 (a) and 4.71 min (b) correspond to
saccharin (sweatening agent) and methyl paraben (preserva-
tive), respectively (Fig. 8). The results obtained are listed in
Table 5. The accuracy and precision were satisfactory to the
label claim.
Conclusion
The proposed HPLC methods can be readily applied for the
simultaneous determination of SAL and GUA (combination I),
of ASC, PAR and GUA (combination II) or of THE, GUA
and AMB (combination III) in their laboratory-made mix-
tures and in pharmaceutical preparations. The proposed meth-
ods are speciﬁc and there is no interference from any of
the sample components. The methods are quite selective, sen-
sitive and are suitable for routine quality control of the three
combinations. The proposed HPLC methods are more sensi-
tive compared with the previously published methods [8,9] ex-
cept for SAL [8].References
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